Literature DB >> 25737041

Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.

Raffaella Migliaccio, Federica Agosta, Katherine L Possin, Elisa Canu, Massimo Filippi, Gil D Rabinovici, Howard J Rosen, Bruce L Miller, Maria Luisa Gorno-Tempini.   

Abstract

The term early-onset Alzheimer's disease (EOAD) identifies patients who meet criteria for AD, but show onset of symptoms before the age of 65. We map progression of gray matter atrophy in EOAD patients compared to late-onset AD (LOAD). T1-weighted MRI scans were obtained at diagnosis and one-year follow-up from 15 EOAD, 10 LOAD, and 38 age-matched controls. Voxel-based and tensor-based morphometry were used, respectively, to assess the baseline and progression of atrophy. At baseline, EOAD patients already showed a widespread atrophy in temporal, parietal, occipital, and frontal cortices. After one year, EOAD had atrophy progression in medial temporal and medial parietal cortices. At baseline, LOAD patients showed atrophy in the medial temporal regions only, and, after one year, an extensive pattern of atrophy progression in the same neocortical cortices of EOAD. Although atrophy mainly involved different lateral neocortical or medial temporal hubs at baseline, it eventually progressed along the same brain default-network regions in both groups. The cortical region showing a significant progression in both groups was the medial precuneus/posterior cingulate.

Entities:  

Keywords:  Age of onset; Alzheimer’s disease; atrophy progression; default mode network; tensor based morphometry; voxel based morphometry

Mesh:

Year:  2015        PMID: 25737041      PMCID: PMC4559486          DOI: 10.3233/JAD-142292

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  69 in total

1.  Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  L A van de Pol; A Hensel; W M van der Flier; P-J Visser; Y A L Pijnenburg; F Barkhof; H Josef Gertz; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

Review 2.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

3.  Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease.

Authors:  Akihiko Shiino; Toshiyuki Watanabe; Kengo Maeda; Emi Kotani; Ichiro Akiguchi; Masayuki Matsuda
Journal:  Neuroimage       Date:  2006-08-10       Impact factor: 6.556

4.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images.

Authors:  Kazunari Ishii; Takashi Kawachi; Hiroki Sasaki; Atsushi K Kono; Tetsuya Fukuda; Yoshio Kojima; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

6.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

7.  Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XII.

Authors:  E Koss; S Edland; G Fillenbaum; R Mohs; C Clark; D Galasko; J C Morris
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

8.  Age at onset and language disturbances in Alzheimer's disease.

Authors:  T Imamura; Y Takatsuki; M Fujimori; N Hirono; Y Ikejiri; T Shimomura; M Hashimoto; H Yamashita; E Mori
Journal:  Neuropsychologia       Date:  1998-09       Impact factor: 3.139

9.  Age at onset and visuocognitive disturbances in Alzheimer disease.

Authors:  M Fujimori; T Imamura; H Yamashita; N Hirono; Y Ikejiri; T Shimomura; E Mori
Journal:  Alzheimer Dis Assoc Disord       Date:  1998-09       Impact factor: 2.703

10.  Early-onset Alzheimer's disease is associated with greater pathologic burden.

Authors:  Gad A Marshall; Lynn A Fairbanks; Sibel Tekin; Harry V Vinters; Jeffrey L Cummings
Journal:  J Geriatr Psychiatry Neurol       Date:  2007-03       Impact factor: 2.680

View more
  25 in total

1.  Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.

Authors:  Winnie Qian; Tom A Schweizer; Nathan W Churchill; Colleen Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; David G Munoz; Joseph J Barfett; Tarek K Rajji; Corinne E Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2018-10-02       Impact factor: 4.105

2.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

3.  Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer's disease.

Authors:  Matthieu Vanhoutte; Franck Semah; Xavier Leclerc; Adeline Rollin Sillaire; Alice Jaillard; Grégory Kuchcinski; Xavier Delbeuck; Rachid Fahmi; Florence Pasquier; Renaud Lopes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

Review 4.  Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review.

Authors:  Clara Sanches; Chloé Stengel; Juliette Godard; Justine Mertz; Marc Teichmann; Raffaella Migliaccio; Antoni Valero-Cabré
Journal:  Front Aging Neurosci       Date:  2021-01-20       Impact factor: 5.750

5.  Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.

Authors:  Jeannie-Marie S Leoutsakos; Haijuan Yan; William S Anderson; Wael F Asaad; Gordon Baltuch; Anna Burke; M Mallar Chakravarty; Kristen E Drake; Kelly D Foote; Lisa Fosdick; Peter Giacobbe; Zoltan Mari; Mary Pat McAndrews; Cynthia A Munro; Esther S Oh; Michael S Okun; Jo Cara Pendergrass; Francisco A Ponce; Paul B Rosenberg; Marwan N Sabbagh; Stephen Salloway; David F Tang-Wai; Steven D Targum; David Wolk; Andres M Lozano; Gwenn S Smith; Constantine G Lyketsos
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 7.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

8.  Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.

Authors:  Jeffrey S Phillips; Sandhitsu R Das; Corey T McMillan; David J Irwin; Emily E Roll; Fulvio Da Re; Ilya M Nasrallah; David A Wolk; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2017-11-06       Impact factor: 5.038

9.  Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Authors:  Meredith L Phillips; Eddie C Stage; Kathleen A Lane; Sujuan Gao; Shannon L Risacher; Naira Goukasian; Andrew J Saykin; Maria C Carrillo; Bradford C Dickerson; Gil D Rabinovici; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2020-01-03       Impact factor: 2.959

10.  Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.

Authors:  Shannon L Risacher; Wesley H Anderson; Arnaud Charil; Peter F Castelluccio; Sergey Shcherbinin; Andrew J Saykin; Adam J Schwarz
Journal:  Neurology       Date:  2017-10-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.